Mitotane 相關新聞
Mitotane 目前有 0 則相關新聞報導,預測適應症 20 個。
本頁整合 Mitotane 的 AI 預測適應症與最新健康新聞,橘色標示的適應症表示近期有相關新聞報導。
藥物資訊
- 原適應症:Symptomatic treatment of advanced (unresectable, metastatic or relapsed) adrenal cortical carcinoma. The effect of Lysodren on non-functional adrenal cortical carcinoma is not established.
- 證據等級:L5
- 預測適應症(20 個):
- multiple endocrine neoplasia(98.0%)
- acne (disease)(97.8%)
- breast fibrocystic disease(93.8%)
- benign mammary dysplasia(93.0%)
- seborrheic keratosis(93.0%)
- vulvar inverted follicular keratosis(92.7%)
- apocrine adenosis of breast(91.8%)
- blunt duct adenosis of breast(91.8%)
- fat necrosis of breast(90.2%)
- breast abscess(90.2%)
- motor nerve neuritis(89.4%)
- vestibular neuronitis(89.3%)
- brachial plexus neuritis(89.0%)
- lactation disease(88.4%)
- neuroretinitis(85.5%)
- breast adenosis(85.0%)
- familial pityriasis rubra pilaris(81.6%)
- candidiasis(81.5%)
- inherited cutis laxa(79.1%)
- alkaptonuria(77.9%)
相關新聞(0 則)
目前沒有相關新聞報導。當有新聞提到此藥物時,系統會自動收集並顯示在這裡。
免責聲明:本頁新聞由系統自動收集,僅供研究參考,不構成醫療建議。